HSPG2 and Schwartz-Jampel syndrome: In contrast, Schwartz-Jampel Syndrome (SJS, OMIM#255800) patients with mutations in the HSPG2 gene that reduce perlecan levels display a less severe phenotype with short stature, kyphosis, skeletal dysplasia, and myotonia [3,4].